GHK-Cu: what the copper peptide actually is
A three-amino-acid molecule with a 50-year research history — explained without the marketing.
TL;DR
- GHK-Cu is a tiny natural peptide that binds one copper atom — first identified in human blood in 1973.
- It has been studied for skin repair, wound healing, and hair follicles over five decades of published research, mostly in lab and animal models.
- Most evidence is on skin. Other research areas have smaller, earlier-stage data.
What it is
GHK-Cu (in plain English: a three-letter peptide — glycine, histidine, lysine — bonded to a copper ion) is one of the smallest peptides studied in medicine. It is naturally present in human plasma (the liquid part of blood). Levels decline with age, per Pickart et al., 2015. Think of GHK-Cu as a copper-carrying shuttle. The copper is the working ingredient. The peptide is the delivery package.
How it works
Copper is involved in dozens of biological processes — wound repair, collagen formation, antioxidant defense. Free copper is reactive and not always safe to circulate alone. GHK-Cu is thought to hold copper in a stable, biologically usable form and carry it to cells. In lab and animal studies, GHK-Cu increased fibroblast activity (in plain English: the cells that produce collagen and elastin, the proteins that keep skin firm) and changed signals tied to wound healing, per Pickart, 2008.
Who asks about it
People come to GHK-Cu after seeing it on a skincare ingredient list and wondering if it actually does anything. Or after a friend mentions a copper-peptide serum. Or as part of a broader curiosity about peptides and skin. The peptide world calls it the "skin peptide" — but the research base is broader than skin.
What the research says
GHK-Cu has one of the longer peer-reviewed track records of any peptide discussed in this category. Most report effects on skin parameters: collagen synthesis, fibroblast activity, wound-closure rates in laboratory and animal models. Human dermatological studies, mostly of topical products, are small; they reported measurable changes in skin firmness and fine-line appearance. The hair-follicle literature is earlier-stage.
What to know
Topical GHK-Cu has a well-tolerated profile per the published literature. Injected GHK-Cu has much less human research. Copper sensitivity is rare but real — anyone with a Wilson's disease history (a copper-handling disorder) should not use it.
The Halftime POV
GHK-Cu is one of the more research-supported peptides in the broader category — partly because it's been studied since the 1970s. Most of that research is lab, animal and small topical studies, and we describe it at that level.
Related reading:
- GHK-Cu topical vs injectable: delivery differences
- Skin peptide research: the published dermatology evidence
- What are peptides? A plain-English primer
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved.
Sources
Frequently asked questions
What is GHK-Cu?
GHK-Cu is a small three-amino-acid peptide that occurs naturally in human blood and binds one copper ion. It was first identified in 1973 and has been studied for skin and wound-healing applications since.
Where does GHK-Cu come from?
It is produced naturally in the body. Preparations used in research and cosmetics are made synthetically and complexed with copper.
Is GHK-Cu just for skin?
Skin research is the largest body of evidence. There is also smaller published literature on hair follicles, wound healing, and lung tissue, though human studies outside dermatology remain limited.
